This gene has also been proposed as a potential biomarker for lung cancer after finding that it interacts with STAT3 in lung cancer cells, regulating IL-6 (Im et al., 2020; Im et al., 2023) and thus mediating inflammatory processes, while another study determined that its blockade inhibited lung cancer cell growth (Won et al., 2014). This evidence concerns the gene IL6 and lung carcinoma.